JP2012532114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532114A5 JP2012532114A5 JP2012517920A JP2012517920A JP2012532114A5 JP 2012532114 A5 JP2012532114 A5 JP 2012532114A5 JP 2012517920 A JP2012517920 A JP 2012517920A JP 2012517920 A JP2012517920 A JP 2012517920A JP 2012532114 A5 JP2012532114 A5 JP 2012532114A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- pharmaceutical composition
- amino acid
- acid sequence
- isolated polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22300509P | 2009-07-03 | 2009-07-03 | |
| US61/223,005 | 2009-07-03 | ||
| PCT/US2010/040949 WO2011003085A1 (en) | 2009-07-03 | 2010-07-02 | Hyr1 as a target for active and passive immunization against candida |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015018131A Division JP2015120722A (ja) | 2009-07-03 | 2015-02-02 | カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532114A JP2012532114A (ja) | 2012-12-13 |
| JP2012532114A5 true JP2012532114A5 (https=) | 2013-08-15 |
| JP5690822B2 JP5690822B2 (ja) | 2015-03-25 |
Family
ID=43411487
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012517920A Active JP5690822B2 (ja) | 2009-07-03 | 2010-07-02 | カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ |
| JP2015018131A Pending JP2015120722A (ja) | 2009-07-03 | 2015-02-02 | カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015018131A Pending JP2015120722A (ja) | 2009-07-03 | 2015-02-02 | カンジダに対する能動免疫及び受動免疫の標的としてのｈｙｒ１ |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8709446B2 (https=) |
| EP (1) | EP2448959B1 (https=) |
| JP (2) | JP5690822B2 (https=) |
| KR (1) | KR20120085234A (https=) |
| CN (1) | CN102574895B (https=) |
| AU (2) | AU2010266114B2 (https=) |
| BR (1) | BR112012000036A2 (https=) |
| CA (1) | CA2766805A1 (https=) |
| ES (1) | ES2606555T3 (https=) |
| IL (1) | IL217261A0 (https=) |
| MX (1) | MX2012000018A (https=) |
| NZ (1) | NZ597442A (https=) |
| RU (2) | RU2559537C2 (https=) |
| SG (1) | SG177456A1 (https=) |
| WO (1) | WO2011003085A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| WO2011003085A1 (en) | 2009-07-03 | 2011-01-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Hyr1 as a target for active and passive immunization against candida |
| GEP201706766B (en) | 2011-07-22 | 2017-10-25 | Los Angeles Biomedical Res Center | Methods and compositions for vaccinating against staphylococcus aureus |
| BR112014005773A2 (pt) * | 2011-09-14 | 2019-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | composições derivadas de hyr1 e métodos of tratamento usando as mesmas |
| WO2014144024A1 (en) * | 2013-03-15 | 2014-09-18 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Hyr1 compositions and methods for treating fungal and bacterial pathogens |
| US10130691B2 (en) | 2013-03-15 | 2018-11-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| GB201306588D0 (en) | 2013-04-11 | 2013-05-29 | King S College London | Peptides and Binding Partners Therefor |
| EP3426287A4 (en) | 2016-03-09 | 2020-03-11 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
| CN113508176A (zh) | 2019-02-28 | 2021-10-15 | 米尼翁大学 | 用于控制白色念珠菌感染的反义寡聚物 |
| CN110229221B (zh) * | 2019-06-27 | 2022-04-12 | 上海交通大学医学院附属仁济医院 | 一种用于检测侵袭性白色念珠菌病的抗原及其用途 |
| US20220354935A1 (en) * | 2021-04-21 | 2022-11-10 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | Vaccination against fungal epitopes to prevent inflammatory bowel diseases |
| WO2025248488A1 (en) * | 2024-05-29 | 2025-12-04 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | Compositions and methods for preventing and treating healthcare-associated candida auris infections with dual antigen vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995031998A1 (en) | 1994-05-23 | 1995-11-30 | The Research & Development Institute, Inc. | Candida albicans adhesin as a vaccine |
| US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US20070077256A1 (en) * | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| US20060083750A1 (en) * | 1999-11-19 | 2006-04-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| US6734344B2 (en) * | 1999-12-10 | 2004-05-11 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agrifood | Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1 |
| US7241613B1 (en) * | 2002-06-05 | 2007-07-10 | Oscient Pharmaceuticals Corporation | Identification of Candida cell surface proteins and their uses |
| RU2316595C1 (ru) * | 2006-06-16 | 2008-02-10 | Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук | Способ получения антимикробного пептида ареницина |
| WO2011003085A1 (en) | 2009-07-03 | 2011-01-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Hyr1 as a target for active and passive immunization against candida |
-
2010
- 2010-07-02 WO PCT/US2010/040949 patent/WO2011003085A1/en not_active Ceased
- 2010-07-02 JP JP2012517920A patent/JP5690822B2/ja active Active
- 2010-07-02 US US13/382,088 patent/US8709446B2/en active Active
- 2010-07-02 CN CN201080039446.5A patent/CN102574895B/zh not_active Expired - Fee Related
- 2010-07-02 ES ES10794828.3T patent/ES2606555T3/es active Active
- 2010-07-02 RU RU2012103502/10A patent/RU2559537C2/ru active IP Right Revival
- 2010-07-02 CA CA2766805A patent/CA2766805A1/en not_active Abandoned
- 2010-07-02 NZ NZ597442A patent/NZ597442A/en not_active IP Right Cessation
- 2010-07-02 SG SG2011097680A patent/SG177456A1/en unknown
- 2010-07-02 KR KR1020127002540A patent/KR20120085234A/ko not_active Withdrawn
- 2010-07-02 RU RU2015122387/10A patent/RU2015122387A/ru not_active Application Discontinuation
- 2010-07-02 EP EP10794828.3A patent/EP2448959B1/en active Active
- 2010-07-02 MX MX2012000018A patent/MX2012000018A/es not_active Application Discontinuation
- 2010-07-02 AU AU2010266114A patent/AU2010266114B2/en not_active Ceased
- 2010-07-02 BR BR112012000036A patent/BR112012000036A2/pt not_active IP Right Cessation
-
2011
- 2011-12-28 IL IL217261A patent/IL217261A0/en unknown
-
2014
- 2014-04-17 US US14/255,072 patent/US20140335114A1/en not_active Abandoned
-
2015
- 2015-02-02 JP JP2015018131A patent/JP2015120722A/ja active Pending
-
2016
- 2016-10-12 AU AU2016244238A patent/AU2016244238A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532114A5 (https=) | ||
| RU2012103502A (ru) | HYR1 В КАЧЕСТВЕ МИШЕНИ ДЛЯ АКТИВНОЙ И ПАССИВНОЙ ИММУНИЗАЦИИ ПРОТИВ Candida | |
| Eskandari et al. | Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering | |
| CN103408669B (zh) | Glp-1类似物融合蛋白，及其制备方法和用途 | |
| Wang et al. | Vaccines in the treatment of invasive candidiasis | |
| CN103071151B (zh) | 猪支原体肺炎疫苗专用稀释剂及其制备方法 | |
| Rivera et al. | Harnessing the immune response to fungal pathogens for vaccine development | |
| CN108025050B (zh) | 昆虫叮咬高敏症的治疗 | |
| JP2015214545A5 (https=) | ||
| JP2012501959A5 (https=) | ||
| US9757441B2 (en) | Anti-Mycoplasma spp. subunit vaccine | |
| JP2015501656A5 (https=) | ||
| JP2015522540A5 (https=) | ||
| JP2014519817A5 (https=) | ||
| EP3715359A1 (en) | Cd4 helper t cell epitope fusion peptide and vaccine therewith | |
| Huai et al. | Genetically engineered virus nanofibers as an efficient vaccine for preventing fungal infection | |
| Yu et al. | A multiepitope vaccine encoding four Eimeria epitopes with PLGA nanospheres: a novel vaccine candidate against coccidiosis in laying chickens | |
| JP2010538619A5 (https=) | ||
| CN102639557A (zh) | 用于治疗毛霉菌病和其它真菌性疾病的疫苗组合物和方法 | |
| US20140271702A1 (en) | Vaccination of Companion Animals to Elicit a Protective Immune Response Against Tick Infestations and Tick-Borne Pathogen Transmission | |
| US9556244B2 (en) | Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission | |
| CN102816221A (zh) | 鸡柔嫩艾美耳球虫ma1基因、载体、重组菌株和蛋白及其应用 | |
| JP2017509597A5 (https=) | ||
| EP2727934A1 (en) | Fusion proteins with representation of different allergens: vaccine proposal for mite allergies | |
| CN102079778B (zh) | 一种抗菌蛋白及其制备方法和应用 |